Literature DB >> 601749

Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin.

A S Carlström, K Liedén, I Björk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 601749     DOI: 10.1016/0049-3848(77)90107-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Authors:  J E Sambrano; L J Jacobson; E B Reeve; M J Manco-Johnson; W E Hathaway
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 3.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

4.  Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

5.  Stoichiometry of reactions of alpha 2-macroglobulin with trypsin and chymotrypsin.

Authors:  I Björk; L J Larsson; T Lindblom; E Raub
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

Review 6.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

Review 7.  Clearance of thrombin in vivo: significance of alternative pathways.

Authors:  T H Carlson
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

8.  Mechanism of inactivation of trypsin by antithrombin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

9.  Evidence for similar conformational changes in alpha 2-macroglobulin on reaction with primary amines or proteolytic enzymes.

Authors:  I Björk; W W Fish
Journal:  Biochem J       Date:  1982-11-01       Impact factor: 3.857

Review 10.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.